Related Experiment Videos
[Carnitine-deficient cardiomyopathy]
K Kádár1, B Melegh, E Szendrei
1Országos Kardiológiai Intézet, Budapest.
Orvosi Hetilap
|February 27, 1994
Insights
Carnitine deficiency in an infant caused neuromuscular and cardiac issues. Oral L-carnitine therapy led to significant improvements in neurological and cardiac function, marking a successful treatment.
Area of Science:
- Pediatric Cardiology
- Neuromuscular Disorders
- Metabolic Diseases
Background:
- Carnitine deficiency is a rare metabolic disorder.
- It can manifest with severe neuromuscular and cardiac symptoms, including dilated cardiomyopathy.
- Early diagnosis and intervention are crucial for patient outcomes.
Observation:
- A 10-month-old infant presented with symptoms suggestive of carnitine deficiency.
- The infant exhibited significant neuromuscular impairment and cardiomyopathy.
- This case represents a rare instance of infantile dilated cardiomyopathy.
Findings:
- Treatment with oral L-carnitine was initiated.
- The infant showed a dramatic improvement in neurological status.
- Cardiac function also saw substantial recovery following L-carnitine supplementation.
Implications:
- This case highlights the efficacy of oral L-carnitine in treating carnitine deficiency-induced cardiomyopathy in infants.
- It underscores the importance of considering metabolic disorders in pediatric cardiomyopathy.
- Successful treatment with L-carnitine offers a promising therapeutic strategy for similar cases.
Abstract:
The case of a 10 month old girl with carnitine deficiency caused neuromuscular symptoms and cardiomyopathy is reported. After oral carnitine therapy dramatic improvement in neurological status and in cardiac function was confirmed. This case is the first infant our country with dilated cardiomyopathy successfully treated by oral L-carnitine.